NCT01125995已完成3 期
A Randomized Phase III Trial for Timing of Radiation in Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 222
- 试验地点
- 3
- 主要终点
- complete response rate
研究概览
简要总结
The purpose of the study is to evaluate the efficacy and toxicity of different timing of concurrent chemoradiation in the treatment of limited disease status Small-cell lung cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •histologically confirmed small-cell lung cancer
- •limited disease status
- •with evaluable disease
- •18 years or older
- •ECOG performance status 0,1,2
- •expected survival time should be 12 weeks or longer
- •Adequate organ function as evidenced by the following; Absolute neutrophil count > 1.5 x 109/L; platelets > 100 x 109/L; total bilirubin ≤1.5 UNL; AST and/or ALT < 5 UNL; creatinine clearance ≥ 50mL/min
- •Written informed consent form
排除标准
- •Uncontrolled systemic illness such as DM, CHF, unstable angina, hypertension or arrhythmia
- •Patients with active infection requiring antibiotics
- •Pregnant or nursing women ( Women of reproductive potential have to agree to use an effective contraceptive method)
- •Prior history of malignancy within 5 years from study entry except for a adequately treated basal cell or squamous cell skin cancer or in situ cervical cancer, well-treated thyroid cancer
- •previous history of chemotherapy or radiotherapy
结局指标
主要结局
complete response rate
时间窗: 6 months
次要结局
- overall survival(36 months)
- objective response rate(6 months)
- Progression-free survival(36 months)
- toxicity by NCI common toxicity version 2.0(36 months)
研究者
Keunchil Park
Professor
Samsung Medical Center
研究点 (3)
Loading locations...
相似试验
已完成
3 期
Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer PatientsColorectal CancerNCT00335595Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)480
终止
3 期
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerNon-small Cell Lung CarcinomaNCT00633568European Lung Cancer Working Party125
已完成
不适用
Clinical Efficacy of Different Revision Times in the Reulceration Rate in Persons with Diabetes and RemissionDiabetic FootNCT06143215Universidad Complutense de Madrid148
招募中
3 期
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryNCT03180268NRG Oncology163
已完成
3 期
Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal MetastasesSpinal MetastasesNCT02320825Memorial Sloan Kettering Cancer Center16
